Literature DB >> 12436012

Very late-onset schizophrenia-like psychosis: clinical and imaging characteristics in comparison with elderly patients with schizophrenia.

Yoram Barak1, Dov Aizenberg, Ilona Mirecki, Doron Mazeh, Anat Achiron.   

Abstract

Studies of late-onset schizophrenia began in the early 1940s with work by M. Bleuler. Despite this fact, the emphasis on age of onset in young adulthood distracted researchers of schizophrenia from accumulating data on the subgroup of patients whose disease onset is in late life. Recently, the diagnostic entity of very late-onset schizophrenia-like psychosis (VLOSLP) was proposed for patients with disease onset after age 60 years, and it may have validity and clinical utility. The present study aims to prospectively identify patients suffering from VLOSLP over a 2-year period and to compare them with elderly schizophrenia patients on measures of brain structure, demographics, and treatment response, so that distinct features, if any, can be identified. Twenty-one VLOSLP patients (15 women, 6 men; mean age, 78.1 years) were enrolled and compared with 21 age- and gender-matched elderly schizophrenia patients. All had undergone brain CT scan, and all were treated with risperidone. The VLOSLP group was characterized by more education, higher percentage being married, more pronounced cerebellar atrophy, and better response to treatment. The authors suggest that VLOSLP is a valid diagnostic entity and that its features imply that involvement of neurodegenerative process may be etiologically relevant to psychosis with onset in late life.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436012     DOI: 10.1097/00005053-200211000-00002

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  13 in total

Review 1.  New wine in old bottle: late-life psychosis.

Authors:  Alana Iglewicz; Thomas W Meeks; Dilip V Jeste
Journal:  Psychiatr Clin North Am       Date:  2011-06

Review 2.  Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?

Authors:  Jakub Z Konarski; Roger S McIntyre; Larry A Grupp; Sidney H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2005-05       Impact factor: 6.186

3.  Study factors influencing ventricular enlargement in schizophrenia: a 20 year follow-up meta-analysis.

Authors:  Angelo Sayo; Robin G Jennings; John Darrell Van Horn
Journal:  Neuroimage       Date:  2011-07-20       Impact factor: 6.556

Review 4.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

5.  [Psychosis in elderly post-traumatic stress disorder patients].

Authors:  G Böwing; K U R Schmidt; G Juckel; S G Schröder
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

6.  [Clinical diagnosis and drug therapy of elderly patients with schizophrenia : A restrospective analysis of data in a department of old age psychiatry].

Authors:  Christian Jagsch; Gabriele Dietmaier; Maximilian Jagsch; Martin Kurz
Journal:  Neuropsychiatr       Date:  2016-06-13

Review 7.  [Diseases of the schizophrenia spectrum disorder in old age : Diagnostic and therapeutic challenges].

Authors:  Christian Jagsch; Alex Hofer
Journal:  Z Gerontol Geriatr       Date:  2018-08-14       Impact factor: 1.281

8.  A Case of Very-late-onset Schizophrenia-like Psychosis.

Authors:  Ji Hyun Son; Baik Seok Kee
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

Review 9.  Secondary psychosis induced by metabolic disorders.

Authors:  Olivier Bonnot; Paula M Herrera; Sylvie Tordjman; Mark Walterfang
Journal:  Front Neurosci       Date:  2015-05-19       Impact factor: 4.677

10.  First-onset functional brief psychoses in the elderly.

Authors:  Yoram Barak; Daniel Levy; Henry Szor; Dov Aizenberg
Journal:  Can Geriatr J       Date:  2011-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.